Nexus Pharma
Plenaris Exosome HGF: Advanced Hair Growth Serum for Thicker, Stronger Hair & Scalp Regeneration
Plenaris Exosome HGF: Advanced Hair Growth Serum for Thicker, Stronger Hair & Scalp Regeneration
Couldn't load pickup availability
Product Overview
Plenaris Exosome HGF is an advanced regenerative medicine formulation developed by Nexus Pharma for the treatment of hair loss and scalp regeneration. The product utilises umbilical cord-derived mesenchymal stromal cell-conditioned media (MSC-CM) exosomes as its primary active delivery system, harnessing the paracrine signalling capabilities of stem cell-derived extracellular vesicles to stimulate dormant hair follicles and promote the anagen growth phase.
Unlike conventional topical hair loss treatments, Plenaris Exosome HGF employs a Root Cause Analysis (RCA) approach to address the multifactorial aetiology of hair thinning, including follicular ageing, perifollicular inflammation, and impaired cellular metabolism. Each treatment kit contains lyophilised exosome powder and reconstitution solution, yielding 5 vials of 5 mL each for professional clinical administration via mesotherapy injection or microneedling.
Specifications
| Manufacturer | Nexus Pharma |
| Product Name | Plenaris Exosome HGF |
| Exosome Count | 25 Million per treatment kit |
| Exosome Source | Umbilical Cord-Derived Mesenchymal Stromal Cell-Conditioned Media (UC-MSC-CM) |
| Key Active Ingredients | IntoCell-HGF, Copper Tripeptide-1, Phyto-NEP, Phytopeptide-1, Oligopeptide-1, Elastin Scalp Peptide, Graviola Leaf Cell Extract |
| Presentation | 5 vials lyophilised powder + 5 vials reconstitution solution (5 x 5 mL) |
| Administration | Mesotherapy injection or microneedling (professional use) |
| Storage | Refrigerated (2-8 degrees C) prior to reconstitution |
| Sterility | Sterile, single-use vials |
| Regulatory | CE marked medical device; manufactured under ISO 13485 and GMP conditions |
| Packaging | Treatment kit (5 treatments per box) |
Clinical Indications
- Androgenetic alopecia (male and female pattern hair loss) stages I-V on the Hamilton-Norwood and Ludwig scales
- Telogen effluvium secondary to stress, nutritional deficiency, or post-partum hormonal changes
- Thinning hair and reduced follicular density requiring follicular neogenesis stimulation
- Post-hair transplant adjunctive therapy to improve graft survival and accelerate healing
- Scalp rejuvenation in patients with compromised scalp microcirculation and perifollicular fibrosis
- Alopecia areata as part of a multimodal treatment protocol under dermatological supervision
Mechanism of Action
The exosome payload delivers hepatocyte growth factor (HGF) and copper tripeptide-1 to restore damaged dermal papilla cells and stimulate follicular stem cell proliferation. Phyto-NEP and Phytopeptide-1 provide antioxidant protection against oxidative stress-mediated follicular damage, while Oligopeptide-1 and Elastin Scalp Peptide enhance keratin, collagen, and elastin synthesis to strengthen the hair shaft and improve structural integrity. Graviola Leaf Cell Extract inhibits 5-alpha reductase activity and DHT-mediated follicular miniaturisation.
Frequently Asked Questions
What is the recommended treatment protocol for Plenaris Exosome HGF?
The standard clinical protocol consists of initial loading sessions administered every 3 weeks for 3-4 treatments, followed by maintenance sessions every 3-4 months. Treatment should be performed by a trained medical professional using mesotherapy injection technique at 4-5 mm depth into the dermal papilla region. The International Society of Hair Restoration Surgery (ISHRS) recommends individualised protocols based on patient response assessment.
How does Plenaris Exosome HGF differ from PRP (Platelet-Rich Plasma) therapy?
While PRP relies on autologous platelet-derived growth factors, Plenaris Exosome HGF utilises allogeneic exosomes containing a standardised concentration of 25 million MSC-derived vesicles. This ensures consistent dosing of growth factors including HGF, VEGF, and KGF across treatments, unlike PRP where growth factor concentrations vary based on patient blood composition and centrifugation protocols.
Is Plenaris Exosome HGF suitable for all hair loss types?
Plenaris Exosome HGF is indicated for androgenetic alopecia, telogen effluvium, and general hair thinning. It is not indicated as monotherapy for scarring alopecias such as lichen planopilaris or frontal fibrosing alopecia. A thorough trichoscopic evaluation by a dermatologist is recommended prior to initiating treatment to confirm appropriate candidacy.
Can Plenaris Exosome HGF be purchased for home use in Singapore?
Plenaris Exosome HGF is a professional-grade medical aesthetic product that requires clinical administration. In Singapore, the product is available through authorised medical distributors including EMIS (Essential Medical International Supplies). Healthcare professionals can purchase directly for clinic use. Patient self-administration is not recommended due to the injection-based delivery method.
What clinical evidence supports exosome therapy for hair restoration?
Published studies in the Journal of Cosmetic Dermatology and Stem Cells Translational Medicine have demonstrated that MSC-derived exosomes promote hair follicle neogenesis by activating the Wnt/beta-catenin signalling pathway. Clinical trials have reported increases in hair density of 15-30% at 12 weeks post-treatment, with improvements in hair shaft diameter and anagen-to-telogen ratio.
Share
